[Skip to Content]
[Skip to Content Landing]
February 1983

Metabolic Acidosis From Acetazolamide Therapy

Author Affiliations

Long Beach, Calif

Arch Ophthalmol. 1983;101(2):303-304. doi:10.1001/archopht.1983.01040010305028

To the Editor.  —The carbonic anhydrase inhibitor acetazolamide is widely used to lower intraocular pressure. It also produces a mild, nonanion gap metabolic acidosis by interfering with the resorption of bicarbonate in the